Market Overview:
The global ranitidine bismuth citrate market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of gastrointestinal disorders, increasing demand for novel therapies, and growing investments by pharmaceutical companies in R&D activities. Based on type, the global ranitidine bismuth citrate market is segmented into 98% purity type, 99% purity type, and others. The 99% purity type segment is expected to grow at a higher CAGR during the forecast period owing to its superior quality and efficacy as compared to other types. Based on application, the global ranitidine bismuth citrate market is segmented into ranitidine bismuth citrate tablets and ranitidine bismuth citrate particles. The Ranitidine Bismuth Citrate Tablets segment accounted for a larger share of the global market in 2017 owing to its widespread use for treating various gastrointestinal disorders.
 Industry Outlook.svg)
Product Definition:
Ranitidine Bismuth Citrate (CAS 128345-62-0) is a compound that is used in the treatment of Helicobacter pylori infection.
98% Purity Type:
98% purity type is a new segment in the ranitidine bismuth citrate (CAS 128345-62-0) market. It has been gaining importance over the past few years on account of its increasing demand from pharmaceutical and biotechnology companies. 98% pure type offers high quality, cost effectiveness, and reliability to end users which has resulted in increased popularity among manufacturers.
98% purity level indicates that there are no other materials except citric acid.
99% Purity Type:
99% purity type is a high-quality pharmaceutical product that has passed through at least one filtration process with a 0.1 micron filter and meets all the requirements of USP 797. It is used to produce ranitidine bismuth citrate, which is an anti-viral medication used for the treatment of viral gastroenteritis and other stomach viruses including Norovirus, Rotavirus infection in children under five years of age as well as adults.
Application Insights:
Ranitidine bismuth citrate tablets were the most prominent application segment and accounted for a revenue share of around 60.0% in 2017. The product is used as an anti-ulcer agent, which has been proven to be effective against gastric and duodenal ulcers. It also finds applications in various other fields including treatment of heartburn, indigestion, nausea & vomiting due to its antacid properties.
The particles form are expected to witness the fastest growth rate over the forecast period owing to their rising applications in pharmaceuticals as well as food additives industries at a global level since past few years together with growing demand from emerging economies such as India & China where there is an increasing incidence of peptic ulcers along with other associated diseases such as gastroenteritis.
Regional Analysis:
Asia Pacific dominated the global ranitidine bismuth citrate market in 2017 and is expected to continue its dominance over the forecast period. The presence of a large number of manufacturers coupled with low production costs in countries such as China, India, and South Korea are some of the major factors contributing to regional growth. In addition, increasing healthcare expenditure by governments along with rising awareness regardingranitidine bismuth citrate tablets & particles use is anticipated to fuel demand forranitidine bismuth citrate over the forecast period.
The U.S., being one of the most developed economies has always been ahead in technological advancements across all sectors be it pharmaceuticals or medical devices or consumer goods etc.
Growth Factors:
- Increasing prevalence of gastrointestinal disorders such as GERD, gastritis, and peptic ulcer disease is expected to drive the growth of Ranitidine Bismuth Citrate (CAS 128345-62-0) market over the forecast period.
- Rising demand for novel therapeutics for the treatment of gastrointestinal disorders is another key factor anticipated to fuel the growth of Ranitidine Bismuth Citrate (CAS 128345-62-0) market in near future.
- Growing geriatric population is another major factor that is likely to boost the demand for Ranitidine Bismuth Citrate (CAS 128345-62-0) in coming years.
- increasing research and development investments by pharmaceutical companies for novel drug development are also projected to propel the growth of global Ranitidine Bismuth Citrate (CAS 128345-62-0) market in next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Research Report
By Type
98% Purity Type, 99% Purity Type, Others
By Application
Ranitidine Bismuth Citrate Tablets, Ranitidine Bismuth Citrate Particles
By Companies
LIVZON, Lanling Pharm, ElSaad Pharma, Shenyuan Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Report Segments:
The global Ranitidine Bismuth Citrate (CAS 128345-62-0) market is segmented on the basis of:
Types
98% Purity Type, 99% Purity Type, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Ranitidine Bismuth Citrate Tablets, Ranitidine Bismuth Citrate Particles
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- LIVZON
- Lanling Pharm
- ElSaad Pharma
- Shenyuan Chemical
 Market Overview.svg)
Highlights of The Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 98% Purity Type
- 99% Purity Type
- Others
- By Application:
- Ranitidine Bismuth Citrate Tablets
- Ranitidine Bismuth Citrate Particles
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ranitidine Bismuth Citrate (CAS 128345-62-0) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ranitidine bismuth citrate is a medication used to treat GERD (gastroesophageal reflux disease). It works by reducing the amount of acid that flows back up the esophagus.
Some of the major players in the ranitidine bismuth citrate (cas 128345-62-0) market are LIVZON, Lanling Pharm, ElSaad Pharma, Shenyuan Chemical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ranitidine Bismuth Citrate (CAS 128345-62-0) Market - Supply Chain
4.5. Global Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Forecast
4.5.1. Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Absolute $ Opportunity
5. Global Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Type
5.3.1. 98% Purity Type
5.3.2. 99% Purity Type
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Application
6.3.1. Ranitidine Bismuth Citrate Tablets
6.3.2. Ranitidine Bismuth Citrate Particles
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ranitidine Bismuth Citrate (CAS 128345-62-0) Demand Share Forecast, 2019-2026
9. North America Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Application
9.4.1. Ranitidine Bismuth Citrate Tablets
9.4.2. Ranitidine Bismuth Citrate Particles
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Type
9.7.1. 98% Purity Type
9.7.2. 99% Purity Type
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ranitidine Bismuth Citrate (CAS 128345-62-0) Demand Share Forecast, 2019-2026
10. Latin America Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Application
10.4.1. Ranitidine Bismuth Citrate Tablets
10.4.2. Ranitidine Bismuth Citrate Particles
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Type
10.7.1. 98% Purity Type
10.7.2. 99% Purity Type
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ranitidine Bismuth Citrate (CAS 128345-62-0) Demand Share Forecast, 2019-2026
11. Europe Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Application
11.4.1. Ranitidine Bismuth Citrate Tablets
11.4.2. Ranitidine Bismuth Citrate Particles
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ranitidine Bismuth Citrte (CAS 128345-62-0) Market Size and Volume Forecast by Type
11.7.1. 98% Purity Type
11.7.2. 99% Purity Type
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ranitidine Bismuth Citrate (CAS 128345-62-0) Demand Share, 2019-2026
12. Asia Pacific Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Application
12.4.1. Ranitidine Bismuth Citrate Tablets
12.4.2. Ranitidine Bismuth Citrate Particles
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Type
12.7.1. 98% Purity Type
12.7.2. 99% Purity Type
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ranitidine Bismuth Citrate (CAS 128345-62-0) Demand Share, 2019-2026
13. Middle East & Africa Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Application
13.4.1. Ranitidine Bismuth Citrate Tablets
13.4.2. Ranitidine Bismuth Citrate Particles
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ranitidine Bismuth Citrate (CAS 128345-62-0) Market Size and Volume Forecast by Type
13.7.1. 98% Purity Type
13.7.2. 99% Purity Type
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ranitidine Bismuth Citrate (CAS 128345-62-0) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Ranitidine Bismuth Citrate (CAS 128345-62-0) Market: Market Share Analysis
14.2. Ranitidine Bismuth Citrate (CAS 128345-62-0) Distributors and Customers
14.3. Ranitidine Bismuth Citrate (CAS 128345-62-0) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. LIVZON
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Lanling Pharm
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. ElSaad Pharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Shenyuan Chemical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
